Latest NLSP reports update at 2024-04-27: 202220212020
NLS Pharmaceutics AG logo

NLS Pharmaceutics AG NLSP

$ 0.13 0.15%

Country

schweizSchweiz

IPO year

2021

Industry

-

Stock Exchange

NASDAQ GLOBAL

CEO

-

Employees in the company

-

Shares

19.7 M

Market Cap[1]

$ 2.56 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.